Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction

• Jeanne Sibiude ,

  * E-mail: jeannesibiude@yahoo.fr

  Affiliation Cochin Hospital, APHP, Paris-Descartes University, Paris, France

  ⨯
• Jean Guibourdenche,

  Affiliations Cochin Hospital, APHP, Paris-Descartes University, Paris, France, PremUP foundation. Paris, France, DHU Risks and Pregnancy, Paris, France

  ⨯
• Marie-Danielle Dionne,

  Affiliations Cochin Hospital, APHP, Paris-Descartes University, Paris, France, University of Montreal, Montreal, Canada

  ⨯
• Camille Le Ray,

  Affiliations Cochin Hospital, APHP, Paris-Descartes University, Paris, France, PremUP foundation. Paris, France, DHU Risks and Pregnancy, Paris, France, INSERM Unit U953, Epidemiological Research Unit on Perinatal Health and Women's and Children's Health, Paris, France

  ⨯
• Olivia Anselem,

  Affiliations Cochin Hospital, APHP, Paris-Descartes University, Paris, France, PremUP foundation. Paris, France, DHU Risks and Pregnancy, Paris, France

  ⨯
• Raphaël Serreau,

  Affiliation Cochin Hospital, APHP, Paris-Descartes University, Paris, France

  ⨯
• François Goffinet,

  Affiliations Cochin Hospital, APHP, Paris-Descartes University, Paris, France, PremUP foundation. Paris, France, DHU Risks and Pregnancy, Paris, France, INSERM Unit U953, Epidemiological Research Unit on Perinatal Health and Women's and Children's Health, Paris, France

  ⨯
• Vassilis Tsatsaris

  Affiliations Cochin Hospital, APHP, Paris-Descartes University, Paris, France, PremUP foundation. Paris, France, DHU Risks and Pregnancy, Paris, France

  ⨯